Review of the safety with biologics in inflammatory bowel disease
Biologics have completely changed the treatment (and life) of patients with inflammatory bowel disease (IBD). After the first ones, anti-tumor necrosis factor (TNF) biologics, two new biologics, with other therapeutic targets, are now in routine use in our patients, and some others are in different...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Publicaciones Permanyer
2022-07-01
|
Series: | Journal of IMIDs |
Subjects: | |
Online Access: | https://www.journalofimids.com/frame_esp.php?id=21 |